Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 79생성일: 2026년 10월 23일
N-(4-chloropyridin-2-yl)cyclopropanecarboxamide → N-[4-(1,3-benzodioxol-4-ylamino)-2-pyridinyl]cyclopropanecarboxamide
https://huagongshe.com/ko/reaction/79
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | N-(4-chloropyridin-2-yl)cyclopropanecarboxamide | HCID 4394171 | — |
| 반응물 | 1,3-Benzodioxol-4-amine | HCID 10313165 | — |
| 시약 | Cesium carbonate | HCID 10796 | — |
| 촉매 | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| 촉매 | Palladium (II) acetate | HCID 4144353 | — |
| 용매 | Dimethylacetamide | HCID 31374 | — |
| 생성물 | N-[4-(1,3-benzodioxol-4-ylamino)-2-pyridinyl]cyclopropanecarboxamide | HCID 127051209 | 50.74% |
반응 단계
benzo[d][1,3]dioxol-4-amine (100 mg, 0.73 mmol), N-(4-chloropyridin-2-yl)cyclopropanecarboxamide (143 mg, 0.73 mmol), XANTPHOS (50.6 mg, 0.09 mmol), PALLADIUM(II) ACETATE (8.19 mg, 0.04 mmol) and CESIUM CARBONATE (475 mg, 1.46 mmol) were suspended in DMA (3mL) and sealed into a microwave tube. The reaction was heated to 150 °C for 1.5 hours in the microwave reactor and cooled to RT. LC/MS showed completion. The crude product was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 0.35M NH3/MeOH and pure fractions were evaporated to dryness to afford N-(4-(benzo[d][1,3]dioxol-4-ylamino)pyridin-2-yl)cyclopropanecarboxamide as a brown oil. The crude product was purified by preparative HPLC using decreasingly polar mixtures of water (containing 1% NH3) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford N-(4-(benzo[d][1,3]dioxol-4-ylamino)pyridin-2-yl)cyclopropanecarboxamide (110 mg, 50.7 %) as a cream solid.
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-0781cd6f039348aeb189dfde52dad6f2 |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|